| Jul 25 |
Actinium wins FDA nod to conduct clinical trial for radiotherapy
|
| Jul 25 |
Actinium Announces FDA Clearance of Iomab-ACT Targeted Conditioning IND Application for Sickle Cell Disease Patients Undergoing Bone Marrow Transplant in Collaboration with Columbia University
|
| Jul 25 |
Actinium Pharmaceuticals to Present at the 3rd Annual Targeted Radiopharmaceuticals Summit US
|
| Jul 11 |
3 Under-$10 Biotech Stocks That Could Make You Rich
|
| Jul 5 |
Actinium Pharmaceuticals: Oversold Despite No Bad News
|
| Jul 2 |
3 Clinical-Stage Biotech Stocks to Buy for Multibagger Returns
|
| Jun 20 |
Is Actinium Pharmaceuticals (ATNM) Outperforming Other Medical Stocks This Year?
|
| Jun 18 |
Treatment of Blood Cancers - Biopharma Companies Building out their Pipeline of Solutions
|
| Jun 17 |
Biopharma Stocks Quest for Solutions for Acute Myeloid Leukemia (AML)
|
| Jun 17 |
Actinium Presents First Ever Data Demonstrating Actimab-A in Combination with Leading Menin Inhibitors Leads to Anti-Tumor Control and Potent Leukemic Cell Killing in Preclinical Acute Myeloid Leukemia Models at the 2024 EHA Congress
|
